- Home /
- Live Rates /
- FOSU

<% signal.analyst %>
<% signal.analyst %>
Last Updated: Feb 23, 2026 04:08:50 PM (GMT)
FOSU: The current market price is 3.9, exhibiting no percentage change from the previous close.
Support and Resistance Levels The support levels are 3.83, 3.8, and 3.79, while resistance levels are 3.9, 3.95, and 4.0. The pivot point is 3.85.
Indicators The RSI is currently at 37.3, indicating neutral strength. The ATR is 0.009, suggesting low volatility. The Parabolic SAR is at 3.83, implying a sideways trend.
Market Sentiment The market displays a neutral trend as it is near the pivot point of 3.85, indicating neither a strong bullish nor bearish scenario.
FOSU Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (FOSU) Fosun International Limited
Company Background
Fosun International Limited, symbol FOSU (TRADU:FOSU), is a diversified global conglomerate headquartered in Shanghai, China. Founded in 1992, Fosun operates across multiple industries including health, happiness (consumer and tourism), wealth (financial services), and smart manufacturing. The company’s mission is to create a healthier, wealthier, and happier lifestyle for families worldwide through innovation and industrial integration. Over the years, Fosun has built an extensive global presence with investments and operations in more than 30 countries, encompassing healthcare services, pharmaceuticals, insurance, tourism, fashion, and high-end manufacturing. Its unique business model combines industrial expertise with investment capabilities, driving long-term value creation across its diverse portfolio.
Market Position
Fosun International holds a leading position among China’s privately owned multinational enterprises, known for its global reach and diversified asset base. The company has established a strong international footprint through strategic acquisitions and partnerships, including stakes in global brands such as Club Med, Lanvin, and Gland Pharma. In the healthcare sector, Fosun Pharma is one of China’s largest pharmaceutical groups, contributing significantly to innovation and global medical supply chains. The company’s financial services division provides insurance, wealth management, and investment products that support individuals and businesses. Fosun’s approach of “Globalization + Innovation + Ecosystem” enables it to integrate global resources while fostering local market competitiveness, positioning it as a key player in China’s outbound investment and global expansion strategy.
Key Financial and Industry Highlights
Fosun International demonstrates resilient financial performance driven by diversified revenue streams across multiple sectors and regions. The company’s balanced portfolio mitigates risks associated with individual industry cycles and global economic fluctuations. Continuous innovation, operational efficiency, and asset optimization remain at the core of its growth strategy. Fosun also places a strong emphasis on sustainable development, ESG initiatives, and digital transformation—leveraging technology to enhance industrial capabilities and service quality. Its global subsidiaries and investments contribute to stable cash flow and long-term asset appreciation.
As global markets adapt to changing consumer trends and sustainability goals, Fosun International is well-positioned to capture growth opportunities in healthcare, tourism, finance, and technology. With its integrated ecosystem, global perspective, and focus on innovation-driven development, Fosun continues to evolve as a dynamic, forward-thinking enterprise. Fosun International Limited stands as a symbol of China’s new generation of global conglomerates, blending industrial strength with international vision to create lasting value worldwide.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>